Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd diagnostic division - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - a chemiluminescent microparticle(cmia) assay for the confirmation of the presence of hbsag in clinical specimens. the architect hbsag qualitative ii confirmatory assay is a chemiluminescent microparticle immunoassay (cmia) for the confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma including specimens collected up to 24 hours post-mortem.

Singapore - English - HSA (Health Sciences Authority)

viatris private limited - latanoprost; timolol maleate 6.83mg/ml eqv timolol - solution - 50 mcg/ml - latanoprost 50mcg/ml; timolol maleate 6.83mg/ml eqv timolol 5mg/ml

Malta - English - Medicines Authority

anfarm hellas s.a. 4 achaias str. & trizinias 14564 kifissia, attiki, greece - fluconazole - capsule - fluconazole 150 mg - antimycotics for systemic use

Malta - English - Medicines Authority

anfarm hellas s.a. 4 achaias str. & trizinias 14564 kifissia, attiki, greece - fluconazole - capsule - fluconazole 50 mg - antimycotics for systemic use

European Union - English - EMA (European Medicines Agency)

eco animal health europe limited - tylvalosin - antiinfectives for systemic use, antibacterials for systemic use, macrolides - pheasants; chicken; turkeys; pigs - pigstreatment and methaphylaxis of swine enzootic pneumonia;treatment of porcine proliferative enteropathy (ileitis);treatment and methaphylaxis of swine dysentery.chickenstreatment and methaphylaxis of respiratory disease associated with mycoplasma gallisepticum in chickens.pheasantstreatment of respiratory disease associated with mycoplasma gallisepticum.turkeystreatment of respiratory disease associated with tylvalosin sensitive strains of ornithobacterium rhinotracheale in turkeys.

European Union - English - EMA (European Medicines Agency)

ceva-phylaxia oltóanyagtermelõ zrt. - inactivated porcine circovirus type 2 (pcv2) - immunologicals for suidae - pigs (gilts and sows) - sows and giltspassive immunisation of piglets via the colostrum, after active immunisation of sows and gilts, to reduce lesions in lymphoid tissues associated with pcv2 infection and as an aid to reduce pcv2-linked mortality.pigletsactive immunisation of piglets to reduce faecal excretion of pcv2 and virus load in blood, and as an aid to reduce pcv2-linked clinical signs, including wasting, weight loss and mortality, as well as to reduce virus load and lesions in lymphoid tissues associated with pcv2 infection.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - inactivated viral and inactivated bacterial vaccines - pigs - for active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused by infection with pcv2.for active immunisation of pigs over the age of 3 weeks against mycoplasma hyopneumoniae to reduce lung lesions caused by infection with m. hyopneumoniae.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - porcine circovirus recombinant virus (cpcv) 1-2, inactivated - immunologicals - pigs (piglets) - active immunisation of pigs over the age of three weeks against porcine circovirus type 2 (pcv2) to reduce viral load in blood and lymphoid tissues, and the lesions in lymphoid tissues associated with pcv2 infection, as well as to reduce clinical signs - including loss of daily weight gain, and mortality associated with post-weaning multisystemic wasting syndrome.

European Union - English - EMA (European Medicines Agency)

ceva santé animale - florfenicol, meloxicam - amphenicols, combinations, antibacterials for systemic use - cattle - for therapeutic treatment of bovine respiratory disease (brd) associated with pyrexia due to mannheimia haemolytica, pasteurella multocida and histophilus somni susceptible to florfenicol.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - calcium gluconate - solution for injection - 100mg/1ml